Medscape November 15, 2024
Miriam E. Tucker

TOPLINE:

Since 1990, the largest increase in diabetes prevalence has occurred in low-income and middle-income countries, whereas improvements in treatment have been greatest in high-income and industrialized nations and some emerging economies, especially in Latin America. These trends have widened the global gap in diabetes prevalence and treatment, with an increasing share of people with diabetes, especially with untreated diabetes, living in low-income and middle-income countries.

METHODOLOGY:

  • In what is believed to be the first global analysis of trends in both diabetes prevalence and treatment coverage over all countries, the investigators analyzed and pooled 1108 population-representative studies with measures of glycemic biomarkers and data on diabetes treatment for a total 141 million adult participants.

TAKEAWAY:

  • In 2022,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Patient / Consumer, Provider, Survey / Study, Trends
Related Articles:
Seniors deserve timely access to care, not bureaucratic hurdles | Viewpoint
From Noise To Clarity, Here’s An Empowering Way To Hearing Health
More than half of US adults could benefit from GLP-1 medications, researchers find
Data show 24.3% of U.S. adults had chronic pain in past three months in 2023
GLP-1 drug coverage for obesity making inroads with large employers: Mercer

Share This Article